MedPath

四川双新制药有限公司

Ownership
-
Established
1998-08-21
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

NMPA:20

Drug Approvals

Cetirizine Hydrochloride Tablets

Product Name
盐酸西替利嗪片
Approval Number
国药准字H20020519
Approval Date
May 11, 2024
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H61020945
Approval Date
May 11, 2024
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H61020948
Approval Date
May 11, 2024
NMPA

Fenofibrate Capsules

Product Name
非诺贝特胶囊
Approval Number
国药准字H20045203
Approval Date
May 11, 2024
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H61020942
Approval Date
May 11, 2024
NMPA

Carvedilol Tablets

Product Name
卓异
Approval Number
国药准字H20031204
Approval Date
May 11, 2024
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H61020944
Approval Date
May 11, 2024
NMPA

Meloxicam Tablets

Product Name
美洛昔康片
Approval Number
国药准字H20040011
Approval Date
May 11, 2024
NMPA

生脉饮

Approval Number
国药准字Z20133050
Approval Date
Jun 12, 2023
NMPA

Sulfogaiacol,Pentoxyverine Citrate and Promethazine Hydrochloride Granules

Product Name
愈酚喷托异丙嗪颗粒
Approval Number
国药准字H51023919
Approval Date
Mar 28, 2022
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.